Pegylated Liposomal Doxorubicin/Trastuzumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of pegylated liposomal doxorubicin and trastuzumab that may be used in the treatment of human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer.

**Synonyms:** - Doxil/Herceptin - Doxorubicin HCl Liposome/Trastuzumab - Pegylated Liposomal Doxorubicin-Trastuzumab - Pegylated Liposomal Doxorubicin/Trastuzumab